Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen P Hunger

Showing results (181-190 of 346) with videos related to

Pageof 35
Sort By:
Pediatric Blood & Cancer|November 20, 2014
Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology GroupWanda L Salzer, Tamekia L Jones, Meenakshi Devidas, et al.
Blood|September 15, 2012
Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28BShuyun Rao, Sang-Yun Lee, Alejandro Gutierrez, et al.
Pediatric Blood & Cancer|May 10, 2025
Human-Centered Design of a Personalized Digital Health Intervention to Improve Oral Chemotherapy Adherence in Adolescents and Young Adults With Hematologic CancersAlexandra M Psihogios, Ayah El-Khatib, Kevin Matos, et al.
Blood Advances|December 28, 2022
Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemiaCarolin Escherich, Wenan Chen, Satoshi Miyamoto, et al.
Journal of Pediatric Hematology/Oncology|June 15, 2016
A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL08P1Vilmarie Rodriguez, John Kairalla, Wanda L Salzer, et al.
Blood|September 28, 2006
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)Kirk R Schultz, D Jeanette Pullen, Harland N Sather, et al.
Leukemia|February 24, 2021
FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631Patrick A Brown, John A Kairalla, Joanne M Hilden, et al.
Blood|August 9, 2023
Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group studyBrent L Wood, Meenakshi Devidas, Ryan J Summers, et al.
Blood Advances|April 15, 2026
Chromosome 15q deletions confer inferior outcomes among children with ETV6::RUNX1 B-Cell Acute Lymphoblastic LeukemiaRuth W Wang'ondu, John A Kairalla, Mary Shago, et al.
Blood|July 1, 2015
Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232Michael J Borowitz, Brent L Wood, Meenakshi Devidas, et al.
Pageof 35

Showing results (181-190 of 346) with videos related to

Sort By:
Pageof 35
Pediatric Blood & Cancer|November 20, 2014
Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology GroupWanda L Salzer, Tamekia L Jones, Meenakshi Devidas, et al.
Blood|September 15, 2012
Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28BShuyun Rao, Sang-Yun Lee, Alejandro Gutierrez, et al.
Pediatric Blood & Cancer|May 10, 2025
Human-Centered Design of a Personalized Digital Health Intervention to Improve Oral Chemotherapy Adherence in Adolescents and Young Adults With Hematologic CancersAlexandra M Psihogios, Ayah El-Khatib, Kevin Matos, et al.
Blood Advances|December 28, 2022
Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemiaCarolin Escherich, Wenan Chen, Satoshi Miyamoto, et al.
Journal of Pediatric Hematology/Oncology|June 15, 2016
A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL08P1Vilmarie Rodriguez, John Kairalla, Wanda L Salzer, et al.
Blood|September 28, 2006
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)Kirk R Schultz, D Jeanette Pullen, Harland N Sather, et al.
Leukemia|February 24, 2021
FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631Patrick A Brown, John A Kairalla, Joanne M Hilden, et al.
Blood|August 9, 2023
Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group studyBrent L Wood, Meenakshi Devidas, Ryan J Summers, et al.
Blood Advances|April 15, 2026
Chromosome 15q deletions confer inferior outcomes among children with ETV6::RUNX1 B-Cell Acute Lymphoblastic LeukemiaRuth W Wang'ondu, John A Kairalla, Mary Shago, et al.
Blood|July 1, 2015
Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232Michael J Borowitz, Brent L Wood, Meenakshi Devidas, et al.
Pageof 35